Mirum Pharmaceuticals, Inc.

Contract Talent Acquisition Specialist

Mirum Pharmaceuticals, Inc.  •  Foster City, CA (Hybrid)  •  11 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

The Talent Acquisition Specialist will serve as a critical operational partner to the Talent Acquisition team, ensuring a seamless and high-quality candidate experience across the full recruitment lifecycle.

This individual will own complex, high-volume interview scheduling across multiple global time zones and act as a key point of coordination between candidates, hiring managers, and interview panels.

In addition to scheduling, this role will provide proactive sourcing support across all departments, helping build robust candidate pipelines and accelerate hiring outcomes. This is a highly detail-oriented, fast-paced role requiring strong communication skills, sound judgment, and the ability to manage competing priorities with precision.

This is initially a contract role averaging 30–40 hours per week with possibility to convert. You will need to be on site a minimum 3 days/week.

Key Responsibilities

Interview Coordination & Candidate Experience

  • Own end-to-end scheduling of phone, video, and onsite interviews across multiple global time zones
  • Coordinate complex, multi-panel interviews while balancing interviewer availability and urgency of roles
  • Serve as a primary point of contact for candidates throughout the interview process
  • Prepare and distribute detailed interview confirmations, logistics, and agendas
  • Manage last-minute changes and reschedules with professionalism and urgency
  • Coordinate candidate debrief meetings and ensure timely feedback
  • Act as onsite coordinator for in-person interviews, ensuring a seamless experience
  • Maintain accurate interview documentation and ATS updates

Sourcing & Pipeline Support

  • Proactively source candidates across multiple departments and functional areas
  • Partner closely with Recruiters and Hiring Managers to understand role requirements and ideal candidate profiles
  • Build and maintain candidate pipelines for current and future hiring needs
  • Support outreach efforts and initial candidate engagement
  • Track sourcing metrics and contribute to continuous process improvement

Operational Excellence

  • Identify and implement scheduling efficiencies and best practices
  • Ensure data integrity within the ATS and calendar systems
  • Maintain confidentiality and professionalism at all times

Qualifications

Education

  • High School Diploma required

Experience

  • 5+ years of experience managing complex, high-volume calendaring required
  • Experience coordinating interviews across international time zones required
  • Experience sourcing candidates across multiple functional areas required
  • Experience in pharmaceutical or biotech industries required
  • Experience with Greenhouse ATS strongly preferred

Knowledge, Skills & Abilities

  • Exceptional attention to detail and organizational skills
  • Ability to manage multiple priorities in a fast-paced environment
  • Strong written and verbal communication skills
  • High level of professionalism and customer-service mindset
  • Proactive, solutions-oriented approach
  • Technically proficient and able to quickly learn new systems
  • Strong sense of urgency and follow-through

#LI-HYBRID

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

Mirum Pharmaceuticals, Inc.

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat), CHOLBAM® (cholic acid) capsules, and CTEXLI™ (chenodiol) tablets.

LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients 12 months of age and older; in Europe, it is approved for patients with PFIC three months of age and older. Mirum is also initiating the Phase 3 EXPAND study, a label expansion opportunity for LIVMARLI in additional settings of cholestatic pruritus. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms of liver disease. CTEXLI is FDA-approved for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.

Mirum's late-stage pipeline includes two investigational treatments for several rare diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2 VISTAS study for primary sclerosing cholangitis (PSC) and Phase 2b VANTAGE study for primary biliary cholangitis (PBC). Volixibat has been granted Breakthrough Therapy Designation for the treatment of cholestatic pruritus in patients with PBC. Mirum is also planning for a Phase 2 study evaluating MRM-3379, a PDE4D inhibitor for the treatment of Fragile X syndrome, a rare genetic neurocognitive disorder.

Industry
Chemicals & Materials
Company Size
201-500 employees
Headquarters
Foster City, CA
Year Founded
2018
Social Media